Fredun Pharma

{
  "main_header": {
    "sid": 1002605,
    "name": "Fredun Pharma",
    "stock_name": "Fredun Pharma",
    "full_name": "Fredun Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/fredun-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,218.00",
    "chg": -26.2,
    "chgp": "-2.11%",
    "dir": -1,
    "prev_price": "1,244.20",
    "mcapval": "2,069.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539730,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE194R01017",
    "curr_date": "Aug 10, 03:30 PM",
    "curr_time": "20:23 PM",
    "last_traded_at": "Aug 10, 03:30 PM IST",
    "bse_nse_vol": "46.64 k",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fredun-pharma-1002605-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Fredun Pharmaceuticals Surges 26.06% in a Week: 5 Key Drivers Behind the Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-surges-2606-in-a-week-5-key-drivers-behind-the-rally-4143197",
        "imagepath": "",
        "date": "2026-08-08 13:07:54",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>3 Aug:</strong> New 52-week high at Rs.1,033 and rating downgraded to Hold</p>\n                    <p><strong>4 Aug:</strong> Fresh 52-week high at Rs.1,112 amid bullish technicals</p>\n                    <p><strong>5 Aug:</strong> New 52-week high at Rs.1,156 and all-time high at Rs.1,188.45; stellar quarterly results announced</p>\n                    <p><strong>6 Aug:</strong> Price correction of -6.97% following rapid gains</p>\n                    <p><strong>7 Aug:</strong> Recovery with +1.83% gain closing at Rs.1,244.20</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div cla..."
      },
      {
        "title": "Are Fredun Pharmaceuticals Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-fredun-pharmaceuticals-ltd-latest-results-good-or-bad-4140386",
        "imagepath": "",
        "date": "2026-08-06 19:22:59",
        "description": "Fredun Pharmaceuticals Ltd has reported strong financial results for the quarter ended June 2026, showcasing significant growth across key metrics. The company achieved net sales of ₹228.25 crores, reflecting a year-on-year growth of 90.45%, which is a notable acceleration compared to previous periods. This marks the highest quarterly sales in the company's history, indicating robust demand and effective market strategies.\n\nNet profit for the same quarter reached ₹13.13 crores, representing a year-on-year increase of 93.94%. This growth in profitability is complemented by an improvement in operating margins, which stood at 14.37%, up from 13.73% in the previous quarter. The company's operational efficiency is further underscored by a return on equity (ROE) of 15.95%, which is significantly above its five-year average, indicating effective capital utilization.\n\nThe company's financial performance has been ch..."
      },
      {
        "title": "265% Stock Return, 89.6% Profit Growth: What's Driving Fredun Pharmaceuticals Ltd's Multibagger Rerating?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-emerges-as-a-multibagger-with-265-returns-amid-robust-growth-4138369",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/FredunPharmaceu_multibagger_4138369.png",
        "date": "2026-08-05 18:10:06",
        "description": "A 265.09% stock return in one year. An 89.6% growth in net profit over the same period. The gap between those two numbers — roughly 175 percentage points — is driven largely by the market's willingness to pay a significantly higher multiple for each rupee of Fredun Pharmaceuticals Ltd's earnings. That premium valuation is the defining feature of this multibagger rally."
      },
      {
        "title": "Fredun Pharmaceuticals Q1 FY27: Stellar Growth Momentum Continues with 94% Profit Surge",
        "link": "https://www.marketsmojo.com/news/result-analysis/fredun-pharmaceuticals-q1-fy27-stellar-growth-momentum-continues-with-94-profit-surge-4138522",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/FredunPharmaceu_quaterlyResult_4138522.png",
        "date": "2026-08-05 17:47:18",
        "description": "Fredun Pharmaceuticals Ltd., a Mumbai-based pharmaceutical formulations manufacturer, delivered an exceptional performance in Q1 FY27 with consolidated net profit surging 93.94% year-on-year to ₹13.13 crores, whilst revenue climbed 90.45% to ₹228.25 crores. The micro-cap company, with a market capitalisation of ₹1,836 crores, saw its stock soar 18.34% following the results announcement, closing at ₹1,313.30 and touching a fresh 52-week high of ₹1,331.70 during intraday trading."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd Reports Outstanding Quarterly Performance Amid Market Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-reports-outstanding-quarterly-performance-amid-market-rally-4138269",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/FredunPharmaceu_fintrenddot_4138269.png",
        "date": "2026-08-05 15:00:10",
        "description": "Fredun Pharmaceuticals Ltd has delivered an outstanding financial performance in the quarter ended June 2026, marking a significant improvement in its financial trend from positive to outstanding. The company’s latest quarterly results reveal record-breaking revenue and profit metrics, alongside a notable expansion in operating margins, signalling robust operational efficiency and strategic execution in a challenging market environment."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd Hits All-Time High of Rs 1,188.45 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-stock-hits-all-time-high-at-rs118845-4138108",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/FredunPharmaceu_priceRelatedfactors_4138108.png",
        "date": "2026-08-05 11:52:51",
        "description": "Extending its winning streak to six consecutive sessions, Fredun Pharmaceuticals Ltd surged to a fresh all-time high of Rs 1,188.45 on 05 Aug 2026, marking a remarkable 20% gain on the day and significantly outpacing the Sensex's modest 0.25% rise."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 1156",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-new-52-week-high-at-rs1156-4137526",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/FredunPharmaceu_priceRelatedfactors_4137526.png",
        "date": "2026-08-05 09:49:15",
        "description": "Surging past its previous peaks, Fredun Pharmaceuticals Ltd touched a new 52-week high of Rs 1156 on 5 Aug 2026, marking a remarkable rally that has seen the stock gain 208.57% over the past year against a Sensex decline of 2.36%. This milestone reflects a powerful momentum driven by a confluence of technical indicators aligning strongly across multiple timeframes."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 1112",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-new-52-week-high-at-rs1112-4135177",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/FredunPharmaceu_priceRelatedfactors_4135177.png",
        "date": "2026-08-04 09:49:27",
        "description": "Surging past its previous peaks, Fredun Pharmaceuticals Ltd reached a fresh 52-week high of Rs 1112 on 4 Aug 2026, marking a remarkable rally of 225.01% over the past year. This milestone comes amid a sustained five-day gain that has propelled the stock 22.69% higher, underscoring strong momentum driven by a confluence of technical indicators and robust price action."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 1033",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-new-52-week-high-at-rs1033-4133259",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/FredunPharmaceu_priceRelatedfactors_4133259.png",
        "date": "2026-08-03 09:50:35",
        "description": ""
      }
    ],
    "total": 310,
    "sid": "1002605",
    "stock_news_url": "https://www.marketsmojo.com/news/fredun-pharmaceuticals-1002605"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "08-Aug-2026",
      "details": "Intimation of Earnings Conference Call for the quarter Q1 of FY27.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Aug-2026",
      "details": "Newspaper Advertisement of the Un-Audited Financial Results for Quarter ended 30th June 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "06-Aug-2026",
      "details": "Press Release issued by Fredun Pharmaceuticals Limited",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Fredun Pharmaceuticals Ltd has declared <strong>7%</strong> dividend, ex-date: 23 Jun 26",
          "dt": "2026-06-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Fredun Pharmaceuticals Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 16 Jul 26",
          "dt": "2026-07-16",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Fredun Pharmaceuticals Surges 26.06% in a Week: 5 Key Drivers Behind the Rally

2026-08-08 13:07:54

Key Events This Week

3 Aug: New 52-week high at Rs.1,033 and rating downgraded to Hold

4 Aug: Fresh 52-week high at Rs.1,112 amid bullish technicals

5 Aug: New 52-week high at Rs.1,156 and all-time high at Rs.1,188.45; stellar quarterly results announced

6 Aug: Price correction of -6.97% following rapid gains

7 Aug: Recovery with +1.83% gain closing at Rs.1,244.20

Week Open

Read full news article

Are Fredun Pharmaceuticals Ltd latest results good or bad?

2026-08-06 19:22:59

Fredun Pharmaceuticals Ltd has reported strong financial results for the quarter ended June 2026, showcasing significant growth across key metrics. The company achieved net sales of ₹228.25 crores, reflecting a year-on-year growth of 90.45%, which is a notable acceleration compared to previous periods. This marks the highest quarterly sales in the company's history, indicating robust demand and effective market strategies. Net profit for the same quarter reached ₹13.13 crores, representing a year-on-year increase of 93.94%. This growth in profitability is complemented by an improvement in operating margins, which stood at 14.37%, up from 13.73% in the previous quarter. The company's operational efficiency is further underscored by a return on equity (ROE) of 15.95%, which is significantly above its five-year average, indicating effective capital utilization. The company's financial performance has been ch...

Read full news article

265% Stock Return, 89.6% Profit Growth: What's Driving Fredun Pharmaceuticals Ltd's Multibagger Rerating?

2026-08-05 18:10:06

A 265.09% stock return in one year. An 89.6% growth in net profit over the same period. The gap between those two numbers — roughly 175 percentage points — is driven largely by the market's willingness to pay a significantly higher multiple for each rupee of Fredun Pharmaceuticals Ltd's earnings. That premium valuation is the defining feature of this multibagger rally.

Read full news article

Fredun Pharmaceuticals Q1 FY27: Stellar Growth Momentum Continues with 94% Profit Surge

2026-08-05 17:47:18

Fredun Pharmaceuticals Ltd., a Mumbai-based pharmaceutical formulations manufacturer, delivered an exceptional performance in Q1 FY27 with consolidated net profit surging 93.94% year-on-year to ₹13.13 crores, whilst revenue climbed 90.45% to ₹228.25 crores. The micro-cap company, with a market capitalisation of ₹1,836 crores, saw its stock soar 18.34% following the results announcement, closing at ₹1,313.30 and touching a fresh 52-week high of ₹1,331.70 during intraday trading.

Read full news article

Fredun Pharmaceuticals Ltd Reports Outstanding Quarterly Performance Amid Market Rally

2026-08-05 15:00:10

Fredun Pharmaceuticals Ltd has delivered an outstanding financial performance in the quarter ended June 2026, marking a significant improvement in its financial trend from positive to outstanding. The company’s latest quarterly results reveal record-breaking revenue and profit metrics, alongside a notable expansion in operating margins, signalling robust operational efficiency and strategic execution in a challenging market environment.

Read full news article

Fredun Pharmaceuticals Ltd Hits All-Time High of Rs 1,188.45 as Momentum Builds Across Timeframes

2026-08-05 11:52:51

Extending its winning streak to six consecutive sessions, Fredun Pharmaceuticals Ltd surged to a fresh all-time high of Rs 1,188.45 on 05 Aug 2026, marking a remarkable 20% gain on the day and significantly outpacing the Sensex's modest 0.25% rise.

Read full news article

Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 1156

2026-08-05 09:49:15

Surging past its previous peaks, Fredun Pharmaceuticals Ltd touched a new 52-week high of Rs 1156 on 5 Aug 2026, marking a remarkable rally that has seen the stock gain 208.57% over the past year against a Sensex decline of 2.36%. This milestone reflects a powerful momentum driven by a confluence of technical indicators aligning strongly across multiple timeframes.

Read full news article

Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 1112

2026-08-04 09:49:27

Surging past its previous peaks, Fredun Pharmaceuticals Ltd reached a fresh 52-week high of Rs 1112 on 4 Aug 2026, marking a remarkable rally of 225.01% over the past year. This milestone comes amid a sustained five-day gain that has propelled the stock 22.69% higher, underscoring strong momentum driven by a confluence of technical indicators and robust price action.

Read full news article

Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 1033

2026-08-03 09:50:35

Read full news article

View All News